Despite their benefits, utility patents also present challenges, particularly in the field of cancer. One major issue is the potential for patent thickets, where overlapping patents create barriers to entry for other researchers and companies, potentially stifling innovation. Additionally, the high cost of patented cancer treatments can limit accessibility for patients, raising ethical concerns about the balance between rewarding innovation and ensuring public health.
